Sanofi SA vs SYSCO Corporation — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while SYSCO Corporation trades at $81.33 (market cap $38.63B). The key difference: Sanofi SA is far larger — about 2.7× SYSCO Corporation's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | SYY | |
|---|---|---|
Market Cap | $104.83B | $38.63B |
Sector | Health | Consumer Staples |
52-Week High | $52.34 | $91.16 |
52-Week Low | $41.33 | $69.30 |
Enterprise Value | $121.32B | $52.11B |
Dividend Yield | 5.5% | 2.72% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →